To further explain this point, a summary review of different immunohistochemical studies demonstrated that although DLBCL has a high expression level of PD-1 and PD-L1, other B-cell lymphomas such as LPL, MCL, and MZL tumor cells are usually negative for PD-L1. The gene discussed is LPL; the disease is neoplasm.